Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
"Rapid and reversible alteration in corneal contour and power associated with Netarsudil/Latanoprost".
Journal: American journal of ophthalmology case reports
Published: July 24, 2021
Safety of cetirizine ophthalmic solution 0.24% for the treatment of allergic conjunctivitis in adult and pediatric subjects.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: March 13, 2019
Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: December 28, 2018
Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: April 25, 2017
Integrated phase III trials of bepotastine besilate ophthalmic solution 1.5% for ocular itching associated with allergic conjunctivitis.
Journal: Allergy and asthma proceedings
Published: September 20, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026